Antiretroviral therapy coverage for PMTCT in Bolivia

Bolivia: Antiretroviral therapy coverage for PMTCT was 98.0% in 2023. ◆ Volatile

Latest (2023)
98.0%
Change on year
up 6.5%
World rank
9th
of 84 countries
All-time high
98.0%
in 2023
All-time low
0.0%
in 2000
Years of data
24
2000–2023

Antiretroviral therapy coverage for PMTCT in Bolivia, 2000–2023

0204060801002000201120232000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 0 % of pregnant women living with HIV2003: 0 % of pregnant women living with HIV2004: 0 % of pregnant women living with HIV2005: 0 % of pregnant women living with HIV2006: 3 % of pregnant women living with HIV2007: 7 % of pregnant women living with HIV2008: 7 % of pregnant women living with HIV2009: 22 % of pregnant women living with HIV2010: 27 % of pregnant women living with HIV2011: 35 % of pregnant women living with HIV2012: 52 % of pregnant women living with HIV2013: 43 % of pregnant women living with HIV2014: 46 % of pregnant women living with HIV2015: 56 % of pregnant women living with HIV2016: 66 % of pregnant women living with HIV2017: 71 % of pregnant women living with HIV2018: 85 % of pregnant women living with HIV2019: 88 % of pregnant women living with HIV2020: 77 % of pregnant women living with HIV2021: 87 % of pregnant women living with HIV2022: 92 % of pregnant women living with HIV2023: 98 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

The most recent figure for antiretroviral therapy coverage for pmtct in Bolivia is 98.0%, measured in 2023. That is the highest value across all 24 years on record.

The figure is up 6.5% on the previous year and up 127.9% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Bolivia peaked at 98.0% in 2023 and was at its lowest, 0.0%, in 2000.

That places Bolivia 9th out of 84 countries with data for 2023, putting it in the top 10%.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Bolivia, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Bolivia, 2000 to 2023.
Year % of pregnant women living with HIV Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 0.0%
2005 0.0%
2006 3.0%
2007 7.0% +133.3%
2008 7.0% +0.0%
2009 22.0% +214.3%
2010 27.0% +22.7%
2011 35.0% +29.6%
2012 52.0% +48.6%
2013 43.0% -17.3%
2014 46.0% +7.0%
2015 56.0% +21.7%
2016 66.0% +17.9%
2017 71.0% +7.6%
2018 85.0% +19.7%
2019 88.0% +3.5%
2020 77.0% -12.5%
2021 87.0% +13.0%
2022 92.0% +5.7%
2023 98.0% +6.5%

Bolivia compared with similar countries

  • Bolivia's 98.0% is above the median for lower middle income countries, which is 83.5%, 1.2× the median. (32 countries reporting)
  • Bolivia's 98.0% is above the median for Latin America & Caribbean, which is 68.0%, 1.4× the median. (15 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Bolivia changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2009 +214.3% 7.0% 22.0%
2007 +133.3% 3.0% 7.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 3.9% 0.0% 22.0% 10
2010s 56.9% 27.0% 88.0% 10
2020s 88.5% 77.0% 98.0% 4

Countries ranked near Bolivia

  1. 9 South Africa 98.0% compare
  2. 9 Zambia 98.0% compare
  3. 12 Cambodia 97.0% compare
  4. 12 Namibia 97.0% compare
  5. 12 Thailand 97.0% compare

See the full ranking of 99 places →

More health data for Bolivia

All data for Bolivia →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Bolivia?
Antiretroviral therapy coverage for pmtct in Bolivia was 98.0% in 2023, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Bolivia?
The highest recorded value was 98.0% in 2023.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Bolivia?
The lowest recorded value was 0.0% in 2000.
How does Bolivia rank for antiretroviral therapy coverage for pmtct?
Bolivia ranks 9th out of 84 countries with data for 2023.
Is antiretroviral therapy coverage for pmtct rising or falling in Bolivia?
Over the last ten years it is up 127.9%. The long-run trend across the full record is volatile.
Where does this Bolivia data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Bolivia. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 18 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/bolivia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/bolivia/">Antiretroviral therapy coverage for PMTCT in Bolivia</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).